196 related articles for article (PubMed ID: 28616249)
1. Quality of Care for Patients With Chronic Kidney Disease in the Primary Care Setting: A Retrospective Cohort Study From Ontario, Canada.
Nash DM; Brimble S; Markle-Reid M; McArthur E; Tu K; Nesrallah GE; Grill A; Garg AX
Can J Kidney Health Dis; 2017; 4():2054358117703059. PubMed ID: 28616249
[TBL] [Abstract][Full Text] [Related]
2. Quality of Chronic Kidney Disease Management in Canadian Primary Care.
Bello AK; Ronksley PE; Tangri N; Kurzawa J; Osman MA; Singer A; Grill AK; Nitsch D; Queenan JA; Wick J; Lindeman C; Soos B; Tuot DS; Shojai S; Brimble KS; Mangin D; Drummond N
JAMA Netw Open; 2019 Sep; 2(9):e1910704. PubMed ID: 31483474
[TBL] [Abstract][Full Text] [Related]
3. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
[TBL] [Abstract][Full Text] [Related]
4. Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations.
Parikh RV; Nash DM; Brimble KS; Markle-Reid M; Tan TC; McArthur E; Khoshniat-Rad F; Sood MM; Zheng S; Pravoverov L; Nesrallah GE; Garg AX; Go AS
Circ Cardiovasc Qual Outcomes; 2020 Sep; 13(9):e006415. PubMed ID: 32873054
[TBL] [Abstract][Full Text] [Related]
5. Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.
Bandak G; Sang Y; Gasparini A; Chang AR; Ballew SH; Evans M; Arnlov J; Lund LH; Inker LA; Coresh J; Carrero JJ; Grams ME
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724651
[TBL] [Abstract][Full Text] [Related]
6. Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis.
Samal L; Wright A; Waikar SS; Linder JA
BMC Nephrol; 2015 Oct; 16():162. PubMed ID: 26458541
[TBL] [Abstract][Full Text] [Related]
7. Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort study.
Schmidt M; Mansfield KE; Bhaskaran K; Nitsch D; Sørensen HT; Smeeth L; Tomlinson LA
BMJ Open; 2017 Jan; 7(1):e012818. PubMed ID: 28069618
[TBL] [Abstract][Full Text] [Related]
8. Kidney Function, ACE-Inhibitor/Angiotensin Receptor Blocker Use, and Survival Following Hospitalization for Heart Failure: A Cohort Study.
Chiu MH; Miller RJH; Barry R; Li B; Har BJ; Wilton SB; Knudtson M; Howlett JG; James MT
Can J Kidney Health Dis; 2018; 5():2054358118804838. PubMed ID: 30349729
[TBL] [Abstract][Full Text] [Related]
9. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury.
Brar S; Ye F; James MT; Hemmelgarn B; Klarenbach S; Pannu N;
JAMA Intern Med; 2018 Dec; 178(12):1681-1690. PubMed ID: 30422153
[TBL] [Abstract][Full Text] [Related]
10. Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a medicaid managed care organization.
Cooke CE; Fatodu H
J Manag Care Pharm; 2006 Oct; 12(8):649-55. PubMed ID: 17269843
[TBL] [Abstract][Full Text] [Related]
11. Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice: a population database study.
Mathieson L; Severn A; Guthrie B
Scott Med J; 2013 May; 58(2):69-76. PubMed ID: 23728750
[TBL] [Abstract][Full Text] [Related]
12. Real-World Diagnosis and Treatment of Diabetic Kidney Disease.
Rodriguez F; Lee DJ; Gad SS; Santos MP; Beetel RJ; Vasey J; Bailey RA; Patel A; Blais J; Weir MR; Dash R
Adv Ther; 2021 Aug; 38(8):4425-4441. PubMed ID: 34254257
[TBL] [Abstract][Full Text] [Related]
13. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.
Rim MY; Ro H; Kang WC; Kim AJ; Park H; Chang JH; Lee HH; Chung W; Jung JY
Am J Kidney Dis; 2012 Oct; 60(4):576-82. PubMed ID: 22658321
[TBL] [Abstract][Full Text] [Related]
14. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
Raebel MA; McClure DL; Simon SR; Chan KA; Feldstein A; Andrade SE; Lafata JE; Roblin D; Davis RL; Gunter MJ; Platt R
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):55-64. PubMed ID: 16470693
[TBL] [Abstract][Full Text] [Related]
15. Effect of Angiotensin Receptor Blocker and Angiotensin Converting Enzyme Inhibitor on Kidney Function and Blood Potassium Level in Indonesian Type 2 Diabetes Mellitus with Hypertension: A Three-Month Cohort Study.
Puspita FM; Yunir E; Agustina PS; Sauriasari R
Diabetes Metab Syndr Obes; 2021; 14():3841-3849. PubMed ID: 34522111
[TBL] [Abstract][Full Text] [Related]
16. Use of Guideline-Based Therapy for Diabetes, Coronary Artery Disease, and Chronic Kidney Disease After Acute Kidney Injury: A Retrospective Observational Study.
Madan S; Norman PA; Wald R; Neyra JA; Meraz-Muñoz A; Harel Z; Silver SA
Can J Kidney Health Dis; 2022; 9():20543581221103682. PubMed ID: 35721395
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C
Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774
[TBL] [Abstract][Full Text] [Related]
18. Processes of Care After Hospital Discharge for Survivors of Acute Kidney Injury: A Population-Based Cohort Study.
Brar S; Ye F; James MT; Harrison TG; Pannu N;
Am J Kidney Dis; 2024 Feb; 83(2):216-228. PubMed ID: 37734688
[TBL] [Abstract][Full Text] [Related]
19. Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate.
Qiao Y; Shin JI; Chen TK; Inker LA; Coresh J; Alexander GC; Jackson JW; Chang AR; Grams ME
JAMA Intern Med; 2020 May; 180(5):718-726. PubMed ID: 32150237
[TBL] [Abstract][Full Text] [Related]
20. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes.
Rosen AB; Karter AJ; Liu JY; Selby JV; Schneider EC
J Gen Intern Med; 2004 Jun; 19(6):669-75. PubMed ID: 15209606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
